Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
KYMR
Stock Latest News
Ratings
Kymera Therapeutics: Promising Growth in Biotechnology with Innovative Degrader Platform and Strategic Partnerships
15h ago
KYMR
Premium
The Fly
Kymera Therapeutics resumed with a Buy at Stifel
15h ago
KYMR
Premium
The Fly
Kymera Therapeutics presents preclinical data for KT-621
1d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target lowered to $70 from $72 at UBS
8d ago
KYMR
Premium
Ratings
Kymera Therapeutics’ Innovative IRF5 Degrader KT-579 Fuels Buy Rating with Promising Growth in Immunology
8d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target lowered to $38 from $41 at B. Riley
8d ago
KYMR
Premium
Ratings
Kymera Therapeutics: Innovative Approaches in Autoimmune Disease Treatment Drive Buy Rating
9d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target lowered to $55 from $60 at BTIG
9d ago
JNJ
KYMR
Premium
The Fly
Kymera Therapeutics price target lowered to $44 from $47 at BofA
9d ago
KYMR
Premium
Ratings
Kymera Therapeutics: Hold Rating Amid Uncertainty in KT-621 and Strategic Shifts
9d ago
KYMR
Premium
Ratings
Kymera Therapeutics: Promising Pipeline Developments and Strategic Decisions Support Buy Rating
9d ago
KYMR
Premium
Ratings
Kymera Therapeutics: Promising Pipeline and Strategic Decisions Justify Buy Rating
9d ago
KYMR
Premium
Company Announcements
Kymera Therapeutics Reports Strong Pipeline Progress
11d ago
KYMR
Premium
Company Announcements
Kymera Therapeutics’ Earnings Call: Resilience and Strategic Growth
11d ago
KYMR
Premium
The Fly
Morning Movers: Pinterest, Lyft jump following quarterly results
11d ago
TU
AGM
Premium
Company Announcements
Kymera Therapeutics Introduces KT-579 Targeting IRF5
12d ago
8K
KYMR
Premium
The Fly
Kymera Therapeutics reports Q1 EPS (82c), consensus (91c)
12d ago
KYMR
Premium
The Fly
Kymera Therapeutics expects cash to provide cash runway into 1H of 2028
12d ago
KYMR
Premium
The Fly
Kymera Therapeutics expands pipeline with IRF5 degrader program
12d ago
KYMR
Premium
Pre-Earnings
KYMR Upcoming Earnings Report: What to Expect?
14d ago
KYMR
Premium
The Fly
Kymera Therapeutics to unveil new oral development candidate
27d ago
KYMR
Premium
The Fly
Kymera Therapeutics announces first patient dosed in BROADEN Phase 1b trial
29d ago
KYMR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
